Published Technical Disclosure Archive

Personalized Cardiac Arrhythmia Treatment in New Applications

Publication ID: 24-11857263_0002_PTD
Published: November 07, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Personalized Cardiac Arrhythmia Treatment in New Applications,” Published Technical Disclosure No. 24-11857263_0002_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857263_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,263.

Summary of the Inventive Concept

The inventive concept extends the core technology of personalized atrial fibrillation ablation to novel industries and use cases, including livestock health monitoring, high-performance athlete care, pet cardiac arrhythmia treatment, personalized cardiac rehabilitation, and remote monitoring.

Background and Problem Solved

The original patent disclosed a personalized atrial fibrillation ablation device for human cardiac arrhythmias. However, the limitations of this technology include its focus on human atrial fibrillation, neglecting the potential benefits for other species and applications. This inventive concept addresses these limitations by adapting the core technology to new industries and use cases, providing a more comprehensive approach to cardiac arrhythmia treatment.

Detailed Description of the Inventive Concept

The inventive concept comprises a system and method for applying the personalized atrial fibrillation ablation technology to various new applications. For instance, Claim 1 describes a system for personalized livestock health monitoring, utilizing a three-dimensional model of a livestock's heart to produce a customized ablation catheter for treating cardiac arrhythmias in livestock. Similarly, Claim 2 outlines a method for predicting and preventing cardiac arrhythmias in high-performance athletes using a personalized atrial fibrillation ablation device. The inventive concept also encompasses a personalized cardiac arrhythmia treatment system for pets, a personalized cardiac rehabilitation program, and a system for remote monitoring and personalized treatment of cardiac arrhythmias.

Novelty and Inventive Step

The inventive concept introduces novel applications and use cases for the personalized atrial fibrillation ablation technology, which are not obvious from the original patent. The new claims demonstrate a non-obvious extension of the core technology to new industries and problems, thereby providing a significant inventive step.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include adapting the technology to other species, such as equine or canine cardiac arrhythmia treatment. Variations may also involve integrating the personalized atrial fibrillation ablation technology with other medical devices, such as pacemakers or implantable cardioverter-defibrillators.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including veterinary care, sports medicine, and remote healthcare monitoring. The target market includes companies and organizations involved in these industries, as well as research institutions and hospitals.

CPC Classifications

SectionClassGroup
A A61 A61B34/10
A A61 A61B18/1492
A A61 A61B2017/00526
A A61 A61B2018/00375
A A61 A61B2018/00577
A A61 A61B2034/104
A A61 A61B2034/105
A A61 A61B2090/374
A A61 A61B2090/378
A A61 A61B2090/3762
A A61 A61M25/0009

Field of Art

Medical Device Technology, Specifically Cardiac Ablation and Personalized Treatment Systems, encompassing interventional cardiology, medical imaging, and precision medical device design

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or interventional cardiologist with advanced training in medical device design, 3D modeling, cardiac electrophysiology, and cross-species medical technology adaptation, possessing expertise in translating medical technologies across different applications

Obviousness Rationale

A PHOSITA would recognize that the core personalized ablation technology disclosed in the source patent represents a generalizable approach to cardiac arrhythmia treatment that can be systematically adapted to different species and medical contexts. The fundamental technical principles of creating patient-specific 3D heart models, designing customized ablation patterns, and developing targeted intervention strategies are inherently transferable across different medical domains. The PTD's variations represent predictable extensions of the source patent's core technological framework, utilizing known medical engineering techniques to apply a proven technological solution to novel contexts.

Obvious Combinations & Variations

Source Patent Element
Three-dimensional personalized heart modeling for atrial fibrillation treatment
PTD Variation
Extending 3D modeling technique to livestock cardiac arrhythmia diagnosis and treatment
Obviousness Reasoning
Predictable application of existing medical imaging and modeling techniques to veterinary medicine, representing a standard design adaptation in biomedical engineering
Source Patent Element
Ablation panel configured to create specific ablation patterns within cardiac tissue
PTD Variation
Adapting ablation panel design for high-performance athlete cardiac monitoring and intervention
Obviousness Reasoning
Known technique of modifying medical device parameters for specialized patient populations, utilizing established technological framework
Source Patent Element
Personalized cardiac intervention using patient-specific anatomical modeling
PTD Variation
Remote monitoring system integrating personalized ablation device with real-time tracking capabilities
Obviousness Reasoning
Predictable technological convergence combining established medical device design with contemporary digital health monitoring approaches
Source Patent Element
Customized ablation catheter design targeting specific cardiac regions
PTD Variation
Extending catheter design principles to pet cardiac arrhythmia treatment
Obviousness Reasoning
Systematic technological translation across species using known medical device engineering principles
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this Published Technical Disclosure would have been obvious to a Person Having Ordinary Skill In The Art at the time of invention, given the teachings of US Patent 11857263. The systematic adaptation of personalized cardiac ablation technology across multiple medical domains represents a predictable technological extension employing standard biomedical engineering methodologies, thereby rendering potential derivative claims non-patentable.

Original Patent Information

Patent NumberUS 11,857,263
TitlePersonalized atrial fibrillation ablation